Skip to main content
. 2017 Sep 28;8:1190. doi: 10.3389/fimmu.2017.01190

Figure 6.

Figure 6

B-cell phenotyping results (%) in probable and possible CVID patients. Abbreviations: B, CD19+ B cells ≤1% of lymphocytes; smB, switched memory B cells ≤2% of B cells; 21low, CD21low cells ≥10% of B cells; Tr-high, transitional B cells ≥9% of B cells (in total, 129 CVID patients had B-cell phenotyping data available. Transitional B cells had been studied in 114 subjects). Asterisks mark statistical significance between “probable” and “possible CVID” patients, *p < 0.01 (χ2-test).